Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

its formal introduction into the local healthcare market. Developed with clinical needs in mind, KrystoLens is designed to help reduce the risk of cross-infection, improve ease of operation, and expand the surgical field of view. Brain Navi...

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Medella Springs, a wellness brand focused on nature-inspired supplements and whole-body support, is helping families navigate the growing conversation around focus, attention, and daily cognitive wellness with AddiVance, a drug-free, non-stimulant...

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

range of MDRO targets. It also supports rapid first-line screening before the availability of culture-based results, helping enable timely infection prevention and control (IPC) responses in hospital settings. The launch reflects Seegene's strategy...

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

area, while also reducing risk of intramuscular injections. Patients benefit from greater stability and depth control, helping insulin get where it needs to go. Together, these features are designed to improve user experience during the injection...

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

older following contact with an individual who has COVID-19.3 This approval introduces the first and only oral option to help prevent COVID-19 after exposure in the current therapeutic landscape, addressing a critical gap in prevention. XOCOVA is a...

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

a patient’s experience, from defining a diagnosis to determining the appropriate treatment to ongoing monitoring. We help accelerate the development of new personalized therapies by leveraging our vast knowledge of precision medicine, real world...

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

of this disease." "I look forward to working with Chaim Lebovits, the Board, and leading ALS centers around the country to help ensure that sound science, regulatory common sense, and a relentless focus on patients bring this promising therapy...

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

“Findings from the BCI Registry Study continue to highlight the real-world impact of the Breast Cancer Index Test in helping physicians make more informed treatment recommendations for their patients.” Detailed findings from the analysis include:...

Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34

stem cells drive relapse in many cancers by overexpressing a stress-response protein called ADAR1, which edits RNA to help tumors hide from the immune system and regenerate after treatment. Aspera’s lead therapeutic, Rebecsinib, acts as a “kill...

Peter Menziuso named EVP and President of BD Interventional

annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

had been reported. “These new data add to the growing body of real-world evidence generated in urology practices and help inform how re-induction with ADSTILADRIN is being evaluated outside of the controlled clinical trial setting, particularly in...

Biohack skin longevity with Futurecode Booster

it. Now, that same mindset is reshaping how we view skin care: with the right inputs and targeted support, we can help optimize our skin's natural systems for repair, strength, and performance. Dermalogica's new FutureCode Booster brings biohacking...

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Smart, Senior Vice President, Mission, Susan G. Komen, said: “Providing patients with early breast cancer more options to help prevent progression to metastatic disease can lead to improved outcomes. Progression and recurrence remain among the most...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

protocols, pupillometry is increasingly being recognized as a way to eliminate subjectivity, improve documentation, and help clinicians identify meaningful changes in pupillary response over time. Recent guidelines from the American College of...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

SIRT1, a member of the sirtuin family, plays an important role in cellular protection and repair. Together, these pathways help protect cells against oxidative stress, inflammation, toxins, and environmental stressors, while also supporting...

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

said David Fairchild, MD, Chief Medical Officer, Retail Health, CVS Health. "By meeting patients where they are, we can help address risk factors earlier which ultimately supports long-term health outcomes and overall health care expenditures."...

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

manufacturing. Kerri brings a strong track record of partnership, operational excellence, and program execution that will help us continue delivering for the clients and patients we serve." McCullough Wood's appointment comes as Avid continues to...

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

behind the BEAR Implant,” Rushdy said. “The opportunity now is to expand use and advance new indications, with the goal of helping people with ACL tears return to an active lifestyle while preserving long-term knee health. I’m excited to work with...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

Co-Founder and CEO of Avenacy. “This presentation enables healthcare providers to deliver safe and efficient care while helping reduce preparation time and potential medication errors, reinforcing our long-standing value proposition as a trusted...

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

clinical trial found that prenatal multivitamins containing 5-methyltetrahydrofolate (5-MTHF) instead of folic acid may help minimize levels of unmetabolized folic acid (UMFA) in pregnant individuals while maintaining adequate folate status in both...